ST. PETERSBURG, FL, Jan. 14, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTCQB: FWDG), a leading provider of advanced
technologies and solutions to the global cannabis industry,
announces today the launch of EssenceTM CBD, a high
concentration, all-natural, Cannabidiol-rich Hemp Oil through its
subsidiary, NutraCann Labs, Inc.
Initial retail sales will be through 1ml cartridges, 10ml &
50ml bottles and starter kits with the sleek URVape vaporizer
pen. Bulk rate kilograms will also be available at the
wholesale level. The product is available immediately online
at www.cbdessence.com and
www.urvape.com . "We
anticipate rolling out a full-line of products relating to CBD in
the very near future. I am excited to be teaming up with our
sister company URVape, Inc. to provide high quality, CBD rich,
vapable hemp oil through "SafeVape" vaporizers online", said CEO of
NutraCann Labs, Inc., Don Ballou.
The Company has spent the last few months ensuring all source
material was free of heavy metals or other toxins. The results of
the company's efforts have made available an absolutely pristine
quality whole-food supplement that represents "the Essence" of the
plant says Don Ballou. There are some hundreds of
phytonutrients that exist in hemp plants and it is absolutely
essential to capture the full spectrum of these valuable &
beneficial molecules. Using Super Critical Extraction
Technology (CO2) makes it possible to extract the essential
phytonutrients without the use of excessive heat or other
undesirable solvents.
NutraCann's Real Pharmaceutical Grade CBD-rich hemp oil comes
from the whole hemp plant and does not contain any synthetics nor
is it an isolate.
FutureWorld is committed to being a leader in the space for
product safety and quality control. With so many snake oils,
imitations and down-right "zero-potency" CBD oil being sold on the
market today at obscene prices, we have made it our cause to bring
much needed legitimacy and integrity back to the market.
"Since our announcement on December 10, 2014, we have received
numerous phone calls, emails, and other inquiries regarding the
sale of our CBD products. While we have already begun to sell some
to wholesale suppliers, we have also created our own brand to make
sure that we can take advantage of the burgeoning retail market,"
commented CEO Sam Talari. "We are determined to create a brand with
CBD EssenceTM that will instill customer trust and
loyalty well into the future. CBD EssenceTM is
only the first in many planned offerings of CBD-infused
pharmaceuticals and nutraceutical under our umbrella."
Tetrahydrocannabinol (THC), the psychoactive phytocannabinoid
(planet-based) found in cannabis, has rapidly become eclipsed by
the non-psychoactive phytocannabinoid, Cannabidiol (CBD), and
derived mainly from Hemp, which is considered to have wider-ranging
medical applications. CBD has even received orphan drug status in
the U.S., fast-tracking the substance for use in treating a severe,
rare form of crippling epilepsy known as Dravet Syndrome. A highly
purified CBD extract developed by UK-based GW Pharmaceuticals, has
now gone into landmark clinical trialing for epilepsy at the
biggest children's hospital in the country with initial trials that
began in April of 2014 which has already shown encouraging results
in kids with treatment-resistant epilepsy. There is increasing
major demand across the board for hemp based CBD oil, due to a
compelling combination of study data, mounting empirical evidence,
and positive feedback from parents whose children suffer from
debilitating seizures.
About FutureWorld Corp
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a
U.S. Diversified Holding Company formed to capitalize on the
burgeoning Cannabis markets globally. FutureWorld, together
with its subsidiaries, focuses on the identification, acquisition,
development, and commercialization of cannabis related products,
such as industrial Hemp. FutureWorld, through its
subsidiaries such as HempTech and CB Scientific, provides personal
and professional THC and CBD test kits, pure CBD oil solutions,
smart sensor technology, communication network, surveillance
security, data analysis for smart cultivation and consultation for
the industrial hemp and legal medicinal cannabis. Our
wireless agricultural smart sensor networks offer precision to the
agriculture, irrigation systems, and greenhouses for the global
cannabis and hemp industry. FutureWorld and its subsidiaries
do not grow, distribute or sell marijuana. To request further
information about FutureWorld, please email us at info@futureworldcorp.com, log
onto our website at http://www.futureworldcorp.com or visit us at our
Facebook page https://www.facebook.com/futureworldenergy.
Forward-Looking Statements
This press release may contain forward-looking statements
covered within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements relate to,
among other things, plans and timing for the introduction or
enhancement of our services and products, statements about future
market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release
that are not historical fact and involve risks and uncertainties.
Our expectations regarding future revenues depend upon our ability
to develop and supply products and services that we may not produce
today and that meet defined specifications. When used in this press
release, the words "plan," "expect," "believe," and similar
expressions generally identify forward-looking statements. These
statements reflect our current expectations. They are subject to a
number of risks and uncertainties, including, but not limited to,
changes in technology and changes in pervasive markets. This
release includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that
are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for
anticipated actions.
CONTACT: Media Contact
FutureWorld Corp
Investor Relations
http://www.futureworldcorp.com
info@futureworldcorp.com
cox@futureworldcorp.com
(727) 474-1816 ext. 103
